06:47Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Discontinuing Intravenous Fluids and a Peripheral Intravenous Line
07:42A Data-Driven Approach to Quantifying Immune States in Sepsis
04:01A Preclinical Model of Sepsis-Induced Myopathy with Disuse in Mice
10:27Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
06:40Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jan 20, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
John A Gallagher1, Diego Aragón-Caqueo2, Arhum Mahmood3
1Department of Internal Medicine, Wayne State University School of Medicine, Detroit, USA.
Treatment access for severe atopic dermatitis (AD) is crucial. Patient support programs (PSPs) help maintain access to immunomodulators like upadacitinib, preventing severe relapses and complications.
Area of Science:
Background: